Research progress on Th17 and T regulatory cells and their cytokines in regulating atherosclerosis

BackgroundCoronary heart disease due to atherosclerosis is the leading cause of death worldwide. Atherosclerosis is considered a chronic inflammatory state in the arterial wall that promotes disease progression and outcome, and immune cells play an important role in the inflammatory process. Purpose...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in cardiovascular medicine 2022-09, Vol.9, p.929078-929078
Main Authors: Wang, Qiong, Wang, Yurong, Xu, Danyan
Format: Article
Language:English
Subjects:
atherosclerosis
Cardiovascular Medicine
CD4+ T cells
IL-17
Th17/Treg balance
Tregs
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:BackgroundCoronary heart disease due to atherosclerosis is the leading cause of death worldwide. Atherosclerosis is considered a chronic inflammatory state in the arterial wall that promotes disease progression and outcome, and immune cells play an important role in the inflammatory process. PurposeWe review the mechanisms of CD4+ T subsets, i.e., helper T17 (Th17) cells and regulatory T cells (Tregs), in regulating atherosclerosis, focusing on the role of interleukin (IL)-17, IL-10, and other cytokines in this disease and the factors influencing the effects of these cytokines. ResultsIL-17 secreted by Th17 cells can promote atherosclerosis, but few studies have reported that IL-17 can also stabilize atherosclerotic plaques. Tregs play a protective role in atherosclerosis, and Th17/Treg imbalance also plays an important role in atherosclerosis. ConclusionThe immune response is important in regulating atherosclerosis, and studying the mechanism of action of each immune cell on atherosclerosis presents directions for the treatment of atherosclerosis. Nevertheless, the current studies are insufficient for elucidating the mechanism of action, and further in-depth studies are needed to provide a theoretical basis for clinical drug development.
ISSN:2297-055X
2297-055X
DOI:10.3389/fcvm.2022.929078